Imaging-Defined Necrosis After Treatment With Single-Fraction Stereotactic Radiosurgery and ICIs and Its Potential Association With Improved Outcomes in Patients With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients
J. Neurosurg. 2022 Sep 16;[EPub Ahead of Print], EJ Lehrer, MS Ahluwalia, J Gurewitz, K Bernstein, D Kondziolka, A Niranjan, Z Wei, LD Lunsford, KR Fakhoury, CG Rusthoven, D Mathieu, C Trudel, TD Malouff, H Ruiz-Garcia, P Bonney, L Hwang, C Yu, G Zada, S Patel, CP Deibert, P Picozzi, A Franzini, L Attuati, RN Prasad, RR Raval, JD Palmer, CC Lee, HC Yang, BM Jones, S Green, JP Sheehan, DM TrifilettiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.